ストックスクリーナーアプリを入手
3.88
0.26%
-0.01
アフターアワーズ：
3.95
0.07
+1.80%
前日終値:
$3.89
開ける：
$3.86
24時間の取引高:
1.05M
Relative Volume:
0.41
時価総額：
$332.09M
収益：
-
当期純損益:
$-36.95M
株価収益率:
-4.619
EPS:
-0.84
ネットキャッシュフロー:
$-33.46M
1週間 パフォーマンス:
-10.60%
1か月 パフォーマンス:
-20.33%
6か月 パフォーマンス:
+30.64%
1年 パフォーマンス:
-49.87%
1日の値動き範囲:
$3.76
$4.0596
1週間の範囲:
$3.76
$4.495
52週間の値動き範囲:
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
名前
Larimar Therapeutics Inc
セクター
電話
844-511-9056
住所
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
LRMR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.88 | 332.95M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-29 | 開始されました | Truist | Buy |
| 2024-10-16 | 開始されました | Oppenheimer | Outperform |
| 2024-10-03 | 開始されました | Wedbush | Outperform |
| 2024-10-02 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-04 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-03 | 開始されました | Leerink Partners | Outperform |
| 2023-11-17 | アップグレード | Citigroup | Neutral → Buy |
| 2022-10-19 | 開始されました | Guggenheim | Buy |
| 2022-02-15 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-02-01 | 開始されました | William Blair | Outperform |
すべてを表示
Larimar Therapeutics Inc (LRMR) 最新ニュース
Why Larimar Therapeutics Inc. stock is favored by pension fundsWeekly Profit Report & Daily Volume Surge Trade Alerts - newser.com
Will Larimar Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
What institutional flow reveals about Larimar Therapeutics Inc.July 2025 Catalysts & Smart Allocation Stock Reports - newser.com
What machine learning models say about Larimar Therapeutics Inc.Earnings Trend Report & Capital Efficient Trade Techniques - newser.com
How moving averages guide Larimar Therapeutics Inc. tradingTrade Risk Summary & Community Trade Idea Sharing - newser.com
Why Larimar Therapeutics Inc. (ZA71) stock stays undervaluedSwing Trade & Community Verified Trade Alerts - newser.com
How geopolitical risks impact Larimar Therapeutics Inc. (ZA71) stockMarket Growth Summary & AI Optimized Trade Strategies - newser.com
Detecting price anomalies in Larimar Therapeutics Inc. with AIJuly 2025 Sentiment & Long-Term Safe Investment Plans - newser.com
Applying chart zones and confluence areas to Larimar Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Larimar Therapeutics Inc. stock retracement – recovery analysisDay Trade & Free Community Consensus Stock Picks - newser.com
How Larimar Therapeutics Inc. stock trades during market volatility2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
How Larimar Therapeutics Inc. (ZA71) stock behaves in tightening cycles2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
Is Larimar Therapeutics Inc. (ZA71) stock positioned for digital growth era2025 Volume Leaders & High Conviction Investment Ideas - newser.com
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Will Larimar Therapeutics Inc. stock benefit from automationEarnings Beat & AI Enhanced Trading Alerts - newser.com
Is Larimar Therapeutics Inc. (ZA71) stock worth buying before Fed actionWeekly Stock Recap & AI Enhanced Market Trend Forecasts - newser.com
Price action breakdown for Larimar Therapeutics Inc.Weekly Gains Summary & Safe Capital Allocation Plans - newser.com
Custom watchlist performance reports with Larimar Therapeutics Inc.July 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Will Larimar Therapeutics Inc. stock gain from lower inflationWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com
What makes Larimar Therapeutics Inc. stock attractive to growth fundsJuly 2025 Volume & Reliable Price Breakout Alerts - newser.com
Pattern recognition hints at Larimar Therapeutics Inc. upsidePortfolio Update Report & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-11-01 00:49:57 - newser.com
Multi factor analysis applied to Larimar Therapeutics Inc.July 2025 Chart Watch & Safe Entry Point Identification - newser.com
What analysts say about Larimar Therapeutics Inc ZA71 stockDividend Aristocrats List & Superior Capital Growth - earlytimes.in
2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Larimar Therapeutics, Inc. (LRMR) And Encourages Shareholders to Reach Out | NDAQ:LRMR | Press Release - Stockhouse
Larimar Therapeutics Advances Phase 1 Study on Nomlabofusp for Friedreich’s Ataxia - MSN
Larimar Therapeutics Inc (LRMR) 財務データ
収益
当期純利益
現金流量
EPS
0.64%
0.35%
大文字化:
|
ボリューム (24 時間):